EXACT SCIENCES CORP Business Acquisition, Pro Forma Revenue
EXACT SCIENCES CORP reported Business Acquisition, Pro Forma Revenue of $2.51 billion for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2026-02-13
- EXACT SCIENCES CORP business acquisition, pro forma revenue for the quarter ending 2023-12-31 was $647.76M, a 16.39% increase year-over-year.
- EXACT SCIENCES CORP business acquisition, pro forma revenue for the quarter ending 2023-09-30 was $629.86M, a 19.79% increase year-over-year.
- EXACT SCIENCES CORP business acquisition, pro forma revenue for the quarter ending 2022-12-31 was $556.53M.
- EXACT SCIENCES CORP business acquisition, pro forma revenue for the quarter ending 2022-09-30 was $525.80M.
- EXACT SCIENCES CORP business acquisition, pro forma revenue for fiscal 2023 was $2.51B, a 19.52% increase from fiscal 2022.
- EXACT SCIENCES CORP business acquisition, pro forma revenue for fiscal 2022 was $2.10B.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|
| 2023-12-31 | $647.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.28B derived: sum of 2 quarters · filed 2026-02-13 | $2.51B 10-K · filed 2026-02-13 | |
| 2023-09-30 | $629.86M 10-Q · filed 2023-11-01 | $1.86B 10-Q · filed 2023-11-01 | ||
| 2022-12-31 | $556.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.08B derived: sum of 2 quarters · filed 2026-02-13 | $2.10B 10-K · filed 2026-02-13 | |
| 2022-09-30 | $525.80M 10-Q · filed 2023-11-01 | $1.54B 10-Q · filed 2023-11-01 |